
               
               
               CLINICAL PHARMACOLOGY:
               
                  Polymyxin B sulfate attacks gram-negative bacilli, including virtually all strains of Pseudomonas aeruginosa and Haemophilus influenzae species.
                  Bacitracin is active against most gram-positive bacilli and cocci including hemolytic streptococci.
               
               
            
         